UK co-ordinating investigator international clinical trial: ReBeL study - a randomized phase I/II trial of lenalidomide and rituximab with or without bendamustine in patients ≥ 18 years with relapsed follicular lymphoma. A HOVON/GLSG/NCRI study.

  • Kim Linton (Other)

Activity: Internal positions, career professional development, other peer review and other › Other › Research

Description

I am the UK co-ordinating investigator for this international phase 1/2 trial
PeriodJun 2015 → …
Held atHOVON, Netherlands
Degree of RecognitionInternational

Keywords

  • bendamustine
  • lenalidomide
  • rituximab
  • Follicular Lymphoma

Research Beacons, Institutes and Platforms

  • Cancer